Systemic mastocytosis is a rare health condition in which too many mast cells (a type of immune system cell) build up in the ...

Cogent Biosciences' uncertain competitive edge may compel investors to sit on the sidelines. Read more about the cautious ...

Indolent systemic mastocytosis (ISM) is one of the five subtypes of systemic mastocytosis, a condition characterized by the ...

Cutaneous mastocytosis (CM) has a low incidence of systemic involvement in children, whereas, systemic mastocytosis (SM) occurs in greater than 25% of adults with CM (Hartmann & Metcalfe ...

The following is a summary of "Comparison of prognostic scores according to WHO classification in 170 patients with advanced ...

Blueprint Medicines' AYVAKIT continues to gain traction among key stakeholders. See more on BPMC stock and the factors ...

Here’s what else the team learned. In Systemic Mastocytosis, What’s the Impact of Type I Interferon Autoantibodies? Investigators from the National Institutes of Health recently tackled the ...

Sudipto Mukherjee, MD, PhD, MPH, of Cleveland Clinic, describes the steps clinicians should take when they encounter clinical abnormalities that may point to systemic mastocytosis. (1:48 ...

Allakos (ALLK – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Jonathan ...

and indolent systemic mastocytosis. The company was founded by Christopher Bebbington, Nenad Tomasevic, Bruce S. Bochner, and Robert Schleimer in 2012 and is headquartered in San Carlos ...

The following is a summary of “Clustering of clinical symptoms using large language models reveals low diagnostic specificity of proposed alternatives to consensus mast cell activation syndrome ...

Interferon alpha-2b (aggressive forms of mastocytosis). Chemotherapy (aggressive systemic mastocytosis). Local radiation for bone pain. Low-dose aspirin is helpful in some patients, because it ...